Hanna Cancer Associates - University of Tennessee
Knoxville, Tennessee, United States
Medical group in Knoxville, Tennessee
Medical Building F, 1926 Alcoa Hwy #380, Knoxville, TN 37920
About Hanna Cancer Associates - University of Tennessee
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
G1 Therapeutics, Inc.
2
Clinical Trials at Hanna Cancer Associates - University of Tennessee
During the past decade, Hanna Cancer Associates - University of Tennessee conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)
2015-06-26
2019-02-22
Completed
122
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
2015-10-05
2021-10-04
Terminated
123
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hanna Cancer Associates - University of Tennessee
According to Clinical.Site data, the most researched conditions in "Hanna Cancer Associates - University of Tennessee" are
"Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Hanna Cancer Associates - University of Tennessee" in a lesser frequency.
Clinical Trials Intervention Types at Hanna Cancer Associates - University of Tennessee
Most popular intervention types in "Hanna Cancer Associates - University of Tennessee" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Trilaciclib" (2 trials), "Carboplatin" (1 trials), "Etoposide" (1 trials) and "Topotecan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hanna Cancer Associates - University of Tennessee
The vast majority of trials in "Hanna Cancer Associates - University of Tennessee" are
2 trials for "All" genders.
Clinical Trials Status at Hanna Cancer Associates - University of Tennessee
Currently, there are NaN active trials in "Hanna Cancer Associates - University of Tennessee".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hanna Cancer Associates - University of Tennessee,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hanna Cancer Associates - University of Tennessee, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".